Veterinary Medicines

COMBI-kel 40, süstesuspensioon 200 mg/ml + 200 mg/ml.

Authorised
  • Benzylpenicillin procaine
  • Dihydrostreptomycin
Download as PDF

Product identification

Medicine name:
COMBI-kel 40, süstesuspensioon 200 mg/ml + 200 mg/ml.
Active substance:
  • Benzylpenicillin procaine
  • Dihydrostreptomycin
Target species:
  • Cattle
  • Pig
  • Dog
  • Cat
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Benzylpenicillin procaine
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        30
        day
      • Milk
        4
        day
    • Pig
      • Meat and offal
        30
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • Kela - Kempisch Laboratorium - Kela Laboratoria
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1193
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 24/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."